CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This research study is for patients with metastatic breast cancer.* Metastatic means that the cancer has spread beyond the ...
Phase 2
Birmingham, Alabama, United States and 19 other locations
to evaluate safety and efficacy of an antibody drug conjugate U3-1402 (patritumab deruxtecan) in patients with locally advanced or metastatic breast...
Phase 2
Birmingham, Alabama, United States and 10 other locations
This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which...
Phase 2
Birmingham, Alabama, United States and 9 other locations
and Lapatinib, given to participants with metastatic triple negative breast cancer that have undergone previous treatment. Velipari ...
Birmingham, Alabama, United States
This research study is studying a combination of drugs as a possible treatment for breast cancer.The drugs involved in this study a...
Phase 2
Birmingham, Alabama, United States and 16 other locations
together. A side effect is anything a drug does besides treating cancer.Participants in this trial have HER2-positive (HER2+) breast...
Phase 2
Birmingham, Alabama, United States and 32 other locations
The human epidermal growth factor receptor 2 (HER2) regulates cell growth and survival. Approximately 15-20% of all breast cancers ...
Phase 1, Phase 2
Birmingham, Alabama, United States and 6 other locations
with pathology-confirmed HR-positive/HER2-negative metastatic breast cancer (MBC) following progression on or after at least two pr...
Phase 2
Birmingham, Alabama, United States of America and 11 other locations
Most physicians still use a one-size-fits-all approach to breast screening in which all women, regardless of their personal history, family ...
Birmingham, Alabama, United States and 10 other locations
Breast cancer is the most common malignancy in the U.S. Targeted therapies such as tamoxifen have been revolutionary in reducing tu ...
Phase 2
Birmingham, Alabama, United States and 7 other locations
Clinical trials
Research sites
Resources
Legal